2-[2-(3-CHLOROPHENYL)ETHYL]-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 97.0%, 250mg

2-Chloroisonicotinaldehyde, 97.0%, 100g

2-(Ethoxycarbonyl)thiazole-4-carboxylic acid, 95.0%, 10g

Methyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate, 95.0%, 1g

1,1,3,3,5,5,7,7,9,9,11,11,13,13-Tetradecamethylheptasiloxane>95.0%(GC)1mL

4',5'-BIS(4-FORMYLPHENYL)-3',6'-DIMETHYL-[1,1':2',1''-TERPHENYL]-4,4''-DICARBALDEHYDE, 95%, 100mg

3-Aminobicyclo[3.2.1]octan-8-ol hydrochloride, 95.0%, 500mg

5-(Piperidin-3-yloxy)-1H-indazole, 98%, 250mg

Columna capilar GC ROTI®Cap-5 MS, 30 m, 0,25 mm, 0,50 µm, 1 Pieza(s)

4-chloro-6-ethyl-2-piperidin-1-ylpyrimidine, 95.0%, 5g

tert-Butyl 6-bromo-4-(difluoromethyl)-1H-indazole-1-carboxylate, 98%, 250mg

2,6-DIFLUOROPYRIDIN-3-OL, 95.0%, 5g

Ethyl 5-bromo-2-methyl-3-nitrobenzoate, 97%, 500mg